Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
International Journal of Geriatric Psychiatry
|
May 4, 2011
Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study
Peter Paul De Deyn, Hans Eriksson, Hanna Svensson, et al.
International Clinical Psychopharmacology
|
November 3, 2011
Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study
Charles Merideth, Andrew J Cutler, Fahua She, et al.
Acta Neuropsychiatrica
|
February 15, 2020
<i>Post hoc</i> analysis of a randomised, placebo-controlled, active-reference 6-week study of brexpiprazole in acute schizophrenia
Stephen R Marder, Hans Eriksson, Yudong Zhao, et al.
The International Journal of Neuropsychopharmacology
|
May 16, 2013
Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy
Michael Bauer, Roger S McIntyre, Johan Szamosi, et al.
Clinical Therapeutics
|
April 28, 2009
Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects
Catherine Datto, Lovisa Berggren, Jitendra B Patel, et al.
Journal of Clinical Psychopharmacology
|
December 20, 2018
Effect of Brexpiprazole on Prolactin: An Analysis of Short- and Long-Term Studies in Schizophrenia
Jelena Ivkovic, Annika Lindsten, Vinu George, et al.
Journal of Affective Disorders
|
October 19, 2013
Effects of extended-release quetiapine fumarate on long-term functioning and sleep quality in patients with Generalized Anxiety Disorder (GAD): data from a randomized-withdrawal, placebo-controlled maintenance study
David V Sheehan, Henrik Svedsäter, Julie C Locklear, et al.
Journal of Biomolecular Screening
|
May 28, 2009
Validation of low-volume 1536-well assay-ready compound plates
Hans Eriksson, Johan Brengdahl, Petter Sandström, et al.
International Journal of Geriatric Psychiatry
|
October 17, 2012
Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder
Irina Mezhebovsky, Kairi Mägi, Fahua She, et al.
International Clinical Psychopharmacology
|
January 8, 2014
Efficacy of once-daily extended release quetiapine fumarate in patients with different levels of severity of generalized anxiety disorder
Stuart A Montgomery, Julie C Locklear, Henrik Svedsäter, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
International Journal of Geriatric Psychiatry
|
May 4, 2011
Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study
Peter Paul De Deyn, Hans Eriksson, Hanna Svensson, et al.
International Clinical Psychopharmacology
|
November 3, 2011
Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study
Charles Merideth, Andrew J Cutler, Fahua She, et al.
Acta Neuropsychiatrica
|
February 15, 2020
<i>Post hoc</i> analysis of a randomised, placebo-controlled, active-reference 6-week study of brexpiprazole in acute schizophrenia
Stephen R Marder, Hans Eriksson, Yudong Zhao, et al.
The International Journal of Neuropsychopharmacology
|
May 16, 2013
Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy
Michael Bauer, Roger S McIntyre, Johan Szamosi, et al.
Clinical Therapeutics
|
April 28, 2009
Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects
Catherine Datto, Lovisa Berggren, Jitendra B Patel, et al.
Journal of Clinical Psychopharmacology
|
December 20, 2018
Effect of Brexpiprazole on Prolactin: An Analysis of Short- and Long-Term Studies in Schizophrenia
Jelena Ivkovic, Annika Lindsten, Vinu George, et al.
Journal of Affective Disorders
|
October 19, 2013
Effects of extended-release quetiapine fumarate on long-term functioning and sleep quality in patients with Generalized Anxiety Disorder (GAD): data from a randomized-withdrawal, placebo-controlled maintenance study
David V Sheehan, Henrik Svedsäter, Julie C Locklear, et al.
Journal of Biomolecular Screening
|
May 28, 2009
Validation of low-volume 1536-well assay-ready compound plates
Hans Eriksson, Johan Brengdahl, Petter Sandström, et al.
International Journal of Geriatric Psychiatry
|
October 17, 2012
Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder
Irina Mezhebovsky, Kairi Mägi, Fahua She, et al.
International Clinical Psychopharmacology
|
January 8, 2014
Efficacy of once-daily extended release quetiapine fumarate in patients with different levels of severity of generalized anxiety disorder
Stuart A Montgomery, Julie C Locklear, Henrik Svedsäter, et al.
Page
of 6